SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Emcure Pharmaceuticals informs about disclosure

27 Nov 2025 Evaluate

Emcure Pharmaceuticals has informed that it enclosed the disclosure regarding a search and seizure/ inspection operation conducted by the Goods & Service Tax Department, Mumbai, Maharashtra, at the Offices of the Company. The operation commenced on November 24, 2025 at 12.15 pm and concluded on November 26, 2025 at 5.00 pm. The relevant details as required pursuant to Regulation 30 and Part A of Schedule III of the SEBI Listing Regulations are provided in ‘Annexure A’, enclosed.

The above information is a part of company’s filings submitted to BSE.

Emcure Pharma Share Price

1670.25 31.85 (1.94%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×